Видео с ютуба B7-H3

DS-7300: the B7-H3 targeting anti-body drug conjugate

A Site-Specific B7-H3 Targeting Antibody-Drug Conjugate for Cancer Therapy

Advancement of B7-H3 targeting CAR T cells against pediatric brain and spinal cord tumors

Holly Meany, MD: SABRE Trial - CAR-TA (B7-H3)

B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinoma

Alpha Lifetech introduce the CD276/B7-H3 Target! 🚀

B7-H3: A Promising New Target in Tumor Immunotherapy

B7-H3 Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of...

Enoblituzumab Unveiling the Role of Anti-B7-H3 in Cancer Research

ADCs in SCLC: Targeting DLL3 and B7-H3 (CD276) - Small Cell Lung Cancer OncInsights 2025-26

The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer

B7-H3 CAR-T Immunotherapy for solid tumors

Phase I/II trial of DB-1311, a B7H3-tageting ADC, in pretreated CRPC

Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR.CD28ζ T cells

Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

Phase I trial of intracranial B7H3 CAR-T therapy in recurrent glioblastoma

B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of...

Non-Viral CRISPR Knock-In Anti-B7-H3 CAR-T Cells for the Treatment of Small Cell Lung Cancer

Замена термостата ,а не прокладки. #automobile

Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates